Home › Cardiomyopathy › Colorado
Cardiomyopathy clinical trials in Colorado
4 studies for Cardiomyopathy are looking for participants at sites in Colorado.
Cities in Colorado
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Aurora
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of Colorado Anschutz, Aurora
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Danon Disease Natural History Study
- Children's Hospital Colorado, Aurora
RecruitingObservational study
Ages 8 and older · All sexes · Updated Jul 28, 2026 · NCT06214507MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- University of Colorado Denver, Denver
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.